PGHL.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 May 2024 @ 05:59):

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements...

Stats
Today's Volume	6 497.00
Average Volume	19 132.00
Market Cap	78.88B
EPS	INR0 ( 2024-05-12 )
Last Dividend	INR45.00 ( 2023-02-13 )
Next Dividend	INR0 ( N/A )
P/E	36.82
ATR14	INR5.66 (0.12%)

Volume Correlation

Long: 0.05 (neutral)

Short: 0.00 (neutral)

Signal:(47.609) Neutral

Procter & Gamble Health Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Procter & Gamble Health Correlation - Currency/Commodity

0.15
( neutral )

0.17
( neutral )

0.28
( neutral )

-0.37
( neutral )

-0.45
( neutral )

-0.36
( neutral )

Procter & Gamble Health Financials

Annual	2022
Revenue:	INR12.30B
Gross Profit:	INR8.68B (70.57 %)
EPS:	INR138.24

FY	2022
Revenue:	INR12.30B
Gross Profit:	INR8.68B (70.57 %)
EPS:	INR138.24

FY	2023
Revenue:	INR0
Gross Profit:	INR0 (0.00 %)
EPS:	INR0

FY	2022
Revenue:	INR10.92B
Gross Profit:	INR7.25B (66.38 %)
EPS:	INR116.00

Financial Reports:

No articles found.

Procter & Gamble Health Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR11.50 (N/A)	INR45.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Procter & Gamble Health Dividend Information - Dividend Junior

Dividend Sustainability Score: 7.59 - good (75.91%) | Divividend Growth Potential Score: 3.39 - Decrease likely (32.18%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR7.80	2003-05-12
Last Dividend	INR45.00	2023-02-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	23	--
Total Paid Out	INR1 058.30	--
Avg. Dividend % Per Year	0.95%	--
Score	2.76	--
Div. Sustainability Score	7.59
Div.Growth Potential Score	3.39
Div. Directional Score	5.49	--

Next Divdend (Est)
(2025-02-05)

INR0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.76

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR15.00	0.68%
2019	INR416.00	13.20%
2020	INR188.00	4.26%
2021	INR90.00	1.29%
2022	INR52.50	1.00%
2023	INR45.00	1.12%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SRF.NS	Dividend Knight	2023-08-01	Semi-Annually	21	0.25%
MPHASIS.NS	Dividend Knight	2023-07-05	Annually	20	1.43%
HERCULES.NS	Dividend Junior	2023-08-03	Annually	17	0.67%
BIGBLOC.NS	Dividend Junior	2023-09-15	Annually	9	0.25%
RBL.NS	Dividend Knight	2023-07-14	Annually	17	1.97%
KOTAKBANK.NS	Dividend Junior	2023-08-04	Annually	23	0.04%
ESABINDIA.NS	Dividend Junior	2023-08-03	Semi-Annually	19	1.52%
ALKEM.NS	Dividend Junior	2023-08-09	Semi-Annually	9	0.71%
TALBROAUTO.NS	Dividend Junior	2023-09-15	Annually	18	0.48%
NEWGEN.NS	Dividend Knight	2023-06-20	Annually	7	2.26%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.183	1.500	6.34	9.51	[0 - 0.5]
returnOnAssetsTTM	0.199	1.200	3.38	4.05	[0 - 0.3]
returnOnEquityTTM	0.281	1.500	7.98	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.35	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.50	0.800	0.0153	0.0122	[0.8 - 2.5]
cashRatioTTM	1.846	1.500	0.854	1.281	[0.2 - 2]
debtRatioTTM	0.0100	-1.500	9.83	-10.00	[0 - 0.6]
interestCoverageTTM	420.77	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0.0134	-1.500	9.95	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.604	1.000	3.26	3.26	[0.2 - 0.8]
operatingProfitMarginTTM	0.248	1.000	7.03	7.03	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.085	0.800	6.10	4.88	[0.5 - 2]
Total Score				7.59

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.53	1.000	6.41	0	[1 - 100]
returnOnEquityTTM	0.281	2.50	8.70	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	5.31	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	46.39	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				3.39

Procter & Gamble Health

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.